Skip to main content
  • Advertise
    Want to Advertise with Us?
    Conquer welcomes advertising and sponsorship collaborations with reputable companies offering high-quality products and services to people affected by cancer.
  • Affiliated Brands
    Academy of Oncology Nurse & Patient Navigators
    The Academy of Oncology Nurse & Patient Navigators (AONN+) is the largest national specialty organization dedicated to improving patient care and quality of life by defining, enhancing, and promoting the role of oncology nurse and patient navigators. Our organization of over 8,900 members was founded in May 2009 to provide a network for all professionals involved and interested in patient navigation and survivorship care services to better manage the complexities of the cancer care treatment continuum for their patients. We view our organization as one consisting of “professional patient advocates” and, to that end, we support and serve our members.
    Journal of Oncology Navigation & Survivorship
    The Journal of Oncology Navigation & Survivorship (JONS) promotes reliance on evidence-based practices in navigating patients with cancer and their caregivers through diagnosis, treatment, and survivorship. JONS also seeks to strengthen the role of nurse and patient navigators in cancer care by serving as a platform for these professionals to disseminate original research findings, exchange best practices, and find support for their growing community.
    The Oncology Nurse-APN/PA
    The Oncology Nurse-APN/PA (TON) provides coverage of the wide spectrum of oncology-related events, trends, news, therapeutics, diagnostics, organizations, and legislation that directly affect hematology/oncology nurses and advanced practitioners involved in healthcare delivery and product utilization. The scope and coverage include a unique presentation of news and events that are shaping the care of patients with cancer.
  • Healthcare Providers
  • Contribute

Does Caffeine Have Hidden Benefits Against Cancer?

Web Exclusives — April 14, 2015

A new study from Lund University in Sweden showed that the risk for breast cancer recurrence was 50% less in women who received the drug tamoxifan and drank at least 2 cups of coffee daily than in women who received tamoxifan but didn’t drink coffee. The researchers found that caffeine and caffeic acid prevented the growth and survival of cancer cells, especially when combined with the drug tamoxifan.

Another January 2015 study from the National Cancer Institute found that people who drank 4 cups of caffeinated coffee daily had a 20% lower risk for melanoma than those who didn’t drink coffee.

In February, a study published in Cancer Epidemiology Biomarkers & Prevention showed that women who drink 4 cups of coffee daily had a reduced risk for endometrial cancer.

Furthermore, an analysis of 34 studies conducted around the world that was published by UK researchers in March revealed that coffee consumption, even just 1 cup daily, reduces the risk for liver cancer.

Although the evidence is promising, it’s too early to say that drinking coffee will protect you from cancer. Researchers still don’t understand how caffeine may prevent cancer growth, and whether other substances in the coffee play a role in that.

Full article: www.forbes.com/sites/arleneweintraub/2015/04/22/parsing-the-latest-evidence-that-aspirin-and-coffee-keeps-cancer-away/

Recommended For You